Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. scores highest on Nitro (91) and lowest on Price (56). Its PosiPenta is 75.02 out of 100, better than most similar companies.
On the Penta Grid this week, Regeneron Pharmaceuticals, Inc. is Grid #2 of 837 in the Healthcare sector in United States, and Grid #8 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 75.02 | 56 | 79 | 91 | 70 | 80 |
| The Cigna Group | 74.25 | 69 | 73 | 95 | 56 | 78 |
| Moderna, Inc. | 48.21 | 6 | 31 | 92 | 49 | 63 |
| Elevance Health, Inc. | 70.42 | 61 | 71 | 98 | 55 | 68 |
| HCA Healthcare, Inc. | 71.08 | 36 | 63 | 78 | 99 | 80 |
| Boston Scientific Corporation | 54.97 | 58 | 68 | 33 | 59 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 19.55 |
| P/B ratio | 2.57 |
EEarnings
| Trailing EPS | ₹3830.27 |
| Forward EPS | ₹5866.32 |
NNitro
| Price | 74894.90 |
| 52-week high | 81392.35 |
| 52-week low | 53619.08 |
| Fall from 52-week high | 8.0% |
TTorque
| Return on equity (ROE) | 14.04% |
| Debt-to-equity | 0.09 |
AAnchor
| Beta (price swings) | 0.15 |
| Market cap | ₹7,71,080 Cr |
| Insider holding | 2.08% |
| Dividend yield | 0.47% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Regeneron Pharmaceuticals, Inc.'s PosiPenta score?
Regeneron Pharmaceuticals, Inc.'s PosiPenta is 75.02 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Regeneron Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Regeneron Pharmaceuticals, Inc. is Grid #2 of 837 in the Healthcare sector in United States, and Grid #8 of 4,000 in United States.
Which PosiPenta pillar is strongest for Regeneron Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 91 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Regeneron Pharmaceuticals, Inc.?
Price (valuation), with a score of 56 out of 100: around the middle of similar companies.
Has Regeneron Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 5.86 points, from 69.16 to 75.02.
PositoAI is for research and education only and is not investment advice.